Analysts expect IGC Pharma, Inc. to report revenue of 193,484.61 for Q4 25, against a range of 176,893.69 to 210,075.53. The most recent reported quarter, Q2 26, came in at 265,000.00, a 55.3% beat against the 170,660.04 consensus.
| Metric | Q3 23 | Q4 23 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 204,000.00 | 295,000.00 | 260,000.00 | 328,000.00 | 191,000.00 | - | 317,000.00 | 265,000.00 | - | - | - | - | - | - | - | |||
| High Estimate | 438,626.83 | 211,430.31 | 349,660.42 | 366,397.35 | 384,949.70 | 210,075.53 | 200,172.95 | 180,638.36 | 97,657.71 | 305,476.25 | 367,384.30 | 292,053.35 | 111,450.78 | 292,413.50 | 383,931.24 | |||
| Low Estimate | 386,653.17 | 198,849.09 | 287,545.58 | 323,073.09 | 345,435.14 | 176,893.69 | 169,150.51 | 160,681.72 | 90,388.05 | 274,073.35 | 304,116.80 | 263,720.55 | 96,319.68 | 244,750.90 | 343,912.22 | |||
| Consensus Estimate | 412,640.00 | 205,139.70 | 318,603.00 | 344,735.22 | 365,192.42 | 193,484.61 | 184,661.73 | 170,660.04 | 94,022.88 | 289,774.80 | 335,750.55 | 277,886.95 | 103,885.23 | 268,582.20 | 363,921.73 |
Analysts expect IGC Pharma, Inc. to report earnings per share of -0.02 for Q3 26, against a range of -0.02 to -0.02. The most recent reported quarter, Q2 26, came in at -0.03, a 50.0% miss against the -0.02 consensus.
| Metric | Q3 23 | Q4 23 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.09 | -0.04 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 | - | - | - | - | - | - | - | - | ||
| High Estimate | -0.04 | -0.04 | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | ||
| Low Estimate | -0.04 | -0.04 | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | ||
| Consensus Estimate | -0.04 | -0.04 | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 |
Pull Wall Street consensus for IGC Pharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IGC&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IGC", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IGC&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();